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EDITORIAL
Hepatosplenic Schistosomiasis: A Tropical Noncirrhosis
In his clinical vignette on schistosomiasis in this issue ofThe YaleJournal Dr. Gil-
berto Reboucas shows us that the art of medicine is not yet dead. As he compares
and contrasts schistosomiasis with cirrhosis, he opens our eyes to a number offas-
cinating and exciting aspects of schistosomiasis. More important, he exposes the
myopic provincialism ofsome ofour concepts ofschistosomiasis as a variant ofcir-
rhosis. Clearly, hepatosplenic schistosomiasis (HSS)is not the tropical equivalent of
cirrhosis.
The approach to schistosomiasis in Bahia, where medical facilities by our stan-
dards are primitive, is simple and direct and, above all, clinical. Although there is
great frustration about the overwhelming magnitude of the problem and their
inability to prevent schistosomiasis, physicians view the situation pragmatically. In
an endemic area schistosomiasis is never overlooked. Cirrhosis may occasionally be
missed, however. The diagnosis is established by the microscopic demonstration of
the ova in the stools and not by more sophisticated, indirect, inferential, immu-
nologic methods. The management of schistosomiasis and, indeed, the whole
practice of medicine in Bahia, is carried out with overtones ofcondomblein a unique
blend ofvoodoo, macumba, and Catholicism.
Since we encounter cirrhosis frequently and schistosomiasis rarely in the overde-
veloped nations, we lose sight of the fact that in the global sense schistosomiasis is
by far the greater problem. We frequently fail to consider schistosomiasis in our
differential diagnoses. Ifone accepts that 2.5% ofAmericans are seriously alcoholic
and that 10% of that population may eventually develop cirrhosis, then up to 500,-
000 cases of cirrhosis will emerge in the United States. By contrast, if 10% of the
patients with schistosomiasis develop HSS, then we are faced with 20,000,000
patients worldwide.
The primary clinical manifestation of HSS is hemorrhage from varices, which is
also the most formidable complication of cirrhosis. Actually, however, the clinical
behavior ofbleeding varices in HSS is much more like hemorrhage following portal
vein thrombosis than it is that ofcirrhosis. In HSS, as in portal vein thrombosis, and
unlike cirrhosis, the total hepatic blood flow is maintained at normal levels by a
compensatory increase in hepatic arterial blood flow. Thus, the liver remains func-
tionally normal. Hepatic parenchymal decompensation does not precede nor follow
variceal hemorrhage. Clotting function is normal, and bleeding tends to stop spon-
taneously or easily with therapy. The liver retains the capacity to extract large loads
ofammonia and other nitrogenous breakdown products ofblood and, consequently,
portalsystemic encephalopathy does not follow each episode ofbleeding. Despite ex-
tensive portalsystemic collateral circulation, patients maintain normal ammonia
tolerance (1). The portal hypertension of HSS is presinusoidal and, consequently,
ascites does not complicate the picture. For all these reasons the mortality rate of
bleeding varices is much lower than in cirrhotic patients. Management of the
bleeding episode is designed to stop the bleeding by use ofesophageal tamponade or
intravenous vasopressin. Definitive treatment is practical and relatively simple.
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Splenectomy and devascularization of varices is easier and more effective than the
portacaval shunt. This has been found in Egyptian HSS (2) as well as in Brazilian.
Certainly, in a disease with a relatively low mortality, prophylactic portacaval
anastomosis has never been seriously considered. As a matter of fact, in the more
temperate areas where it has been tried, this prophylactic procedure has failed.
Why HSS causes preferential hypertrophy of the left lobe is not clear. Why ab-
dominal collateral veins do not develop is not known. The reason for schistosomal
cor pulmonale is known, however. After portal hypertension has induced the de-
velopment of portalsystemic collateral vessels, the ova deposited into the portal
venules bypass the liver and reach the lung, where they cause pulmonary hyperten-
sion due to extensive pulmonary microembolization.
Some of the most fascinating aspects of schistosomiasis have been brought to
light by the magnificent investigations of Dr. Kenneth Warren and his associates
using the mouse model he developed (3). The whole syndrome can be rapidly re-
produced by the exposure of mice to known numbers of the infectious schistosome
cercariae. The organisms penetrate the skin, migrate first to the lungs and then to
the liver, where they grow to adult worms and mate.
The love affair of the schistosome worms is truly beautiful and worthy of
emulation. If two cercariae, a male and a female, are introduced into the body, they
wend their tortuous ways to the liver where, in the endless tributaries ofthe intrahe-
patic portal veins, they somehow find each other. How? What is their love call? It
gives new meaning to the old ballad cliche that "they were meant for each other."
Furthermore, as they emigrate to the mesenteric venules, they pledge vows of
eternal love and spend their lives in pure monogamous bliss. For years the female
remains lovingly embraced in the folds of the male in a state that can enviously be
termed in copuloperpetuo.
The products ofthis happy union aredeposited in the mesenteric veins. About half
of these ova enzymatically cleave their way into the intestinal tract. The others are
carried downstream until they can no longer pass through the narrowing portal
venules and finally come to rest obstructing a terminal branch of the vein they
entered. Actually, it is the intense granulomatous response induced by each egg that
causes the hemodynamic changes rather than the mechanical obstruction of the
vessel by the ovum. This vigorous, cell-mediated, immunologic reaction ofdelayed
hypersensitivity is the hallmark of this immunologic disease. These granulomata
eventually mature and become fibrous. The fibrotic changes may become extensive
but never actually produce a true cirrhosis.
The most exciting aspect of Dr. Rebougas' paper is the preliminary report that
HSS seems to be associated in some way with the hepatitis B virus (HBV). The key
observation was made by Cheever and Andrade in 1970(4). These authors found in a
carefully controlled, blindly studied manner that the hepatic histologic abnor-
malities in decompensated HSS were indistinguishable from those of chronic active
hepatitis (CAH) (5). More recently Dr. Rebougas' colleagues in Bahia have found an
increased prevalence of persistent HBV surface antigenemia in patients with HSS,
especially those with thedecompensated disease (6, 7).
These findings imply that either the HBV finds the schistosomotic patient a hos-
pitable host and can thus induce CAH or that the presence of HBV tends to ag-
gravate or accelerate the schistosomal lesion, or both. In the mouse the severity of
HSS is directly related to the degree ofinfestation, i.e., to the number of cercariae
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introduced. It is also felt that the HBV can induce CAH by itself, but it is not known
whether or what other factors are necessary. Similarly, chronic active liver disease
can be induced by drugs such as oxyphenisatin (8), isoniazid (9), and a-methyldopa
(10). There is reason to believe alcohol, too, may induce chronic active liver disease
that persists long after alcohol abuse has ended (11). Alcoholic hepatitis may well in-
duce or be the consequence ofan immunologic reaction to alcohol hyalin, an altered
hepatic parenchymal tissue (12). Evidence of anergy to skin tests, an acquired im-
munologic abnormality ofdelayed hypersensitivity, has been observed (13). Each of
these disorders has overtones ofimmunologic disturbance. Is an underlying consti-
tutional predisposition necessary for such disorders to develop? Does the acquired
immunopathologic state induced by schistosome ova favor the development of
CAH? Certainly, schistosomiasis seems to offer some clues and a means of
investigating some ofthe dark mysteries.
The eradication of schistosomiasis poses an enormous problem. On a recent visit
to Bahia the magnitude and complexity ofthe problem was dramatically brought to
my attention. Dr. Rebougas had taken my wife and me to a beautiful, blue-black
lake surrounded by white sand dunes. There, under clear, sunny skies, was a gor-
geous sight. The lake was ringed ty women washing clothes and by colorful clothing
spread on the bushes to dry. In the shallow water along the edge children were
wading in the water and splashing each other.
My wife commented what a lovely, idyllic scene it was with the women washing
together and helping each other to spread their garments on the bushes and the
children frolicking in the water. When he pointed out to her that, as wewatched, the
women and children were getting schistosomiasis, she was horrified and aggressively
challenged our host.
"Why aren't there warning signs posted all around the lake?" she demanded.
"First, we must teach them to read," he replied sadly. "Then we must teach them
to understand."
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